{"nct_id":"NCT02719574","title":"Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation","status":"COMPLETED","status_verified_date":"2025-06","start_date":"2016-04-30","start_date_type":"ACTUAL","primary_completion_date":"2023-12-28","primary_completion_date_type":"ACTUAL","completion_date":"2024-01-24","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["NVO"]}